Angiotensin-converting enzyme polymorphism in patients with terminal renal failure.
Alice Schmidt, Gert Mayer(University of Vienna), A. Illievich(University of Vienna), Martin Auinger(Klinik Hietzing), Alexandra Kaider, Isis Arias(University of Vienna), Ursula Barnas(University of Vienna), H. Kiener(University of Vienna), W. Graninger(Medical University of Graz)
Cited by 31
Related Papers
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
|Annals of the Rheumatic Diseases|2014|726
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
|The Lancet|2019|609
Erythropoietin Treatment of Anemia Associated with Multiple Myeloma
|New England Journal of Medicine|1990|450
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)
|Annals of the Rheumatic Diseases|2016|355
Risk of pregnancy‐associated recurrent venous thromboembolism in women with a history of venous thrombosis
|Journal of Thrombosis and Haemostasis|2005|224